Drug interactions that matter. A critical reappraisal
- PMID: 3063497
- DOI: 10.2165/00003495-198836010-00006
Drug interactions that matter. A critical reappraisal
Abstract
Drug interactions are ubiquitous but those with proven clinical relevance are much less common. Only when the combined effects of the interacting drugs are greater or less than the arithmetic sum of their individual actions can the event be considered a true interaction. This eliminates many candidate 'interactions' which in reality merely describe the summation of similar or opposing, but independent, drug effects. An appreciation of those drug interactions that really do matter can be best achieved by combining a practical knowledge of the pharmacological mechanisms involved with awareness of the most vulnerable patients (those with little reserve capacity) and the drugs associated with the greatest risk (those with a narrow therapeutic index). This review follows these guidelines and provides an account of well documented drug interactions categorised according to mechanism.
Similar articles
-
Drug interactions of clinical significance with opioid analgesics.Drug Saf. 1993 Jan;8(1):30-48. doi: 10.2165/00002018-199308010-00005. Drug Saf. 1993. PMID: 8471186 Review.
-
Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.Clin Pharmacokinet. 1990 Jul;19(1):44-66. doi: 10.2165/00003088-199019010-00004. Clin Pharmacokinet. 1990. PMID: 2199127 Review.
-
Health implications of drug interactions.Drug Saf. 1990;5 Suppl 1:84-7. doi: 10.2165/00002018-199000051-00013. Drug Saf. 1990. PMID: 2182068 Review.
-
Pharmacokinetic drug interactions with oral contraceptives.Clin Pharmacokinet. 1990 Jun;18(6):472-84. doi: 10.2165/00003088-199018060-00004. Clin Pharmacokinet. 1990. PMID: 2191822 Review.
-
Avoiding drug interactions.Prescrire Int. 2004 Jun;13(71):99-102. Prescrire Int. 2004. PMID: 15233147
Cited by
-
Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature.Eur J Clin Pharmacol. 2005 Jul;61(5-6):327-35. doi: 10.1007/s00228-005-0943-4. Epub 2005 Jun 28. Eur J Clin Pharmacol. 2005. PMID: 15983822
-
Drug interactions of clinical significance with opioid analgesics.Drug Saf. 1993 Jan;8(1):30-48. doi: 10.2165/00002018-199308010-00005. Drug Saf. 1993. PMID: 8471186 Review.
-
["Clinically significant" new drug interactions].Med Klin (Munich). 1999 Feb 15;94(2):120-4. doi: 10.1007/BF03044714. Med Klin (Munich). 1999. PMID: 10194960 Review. German.
-
Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.Clin Pharmacokinet. 1990 Jul;19(1):44-66. doi: 10.2165/00003088-199019010-00004. Clin Pharmacokinet. 1990. PMID: 2199127 Review.
-
Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder.Drug Saf. 2011 Sep 1;34(9):733-54. doi: 10.2165/11592790-000000000-00000. Drug Saf. 2011. PMID: 21830836 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical